Skip to main content

Advertisement

SpringerLink
Log in

Genetic polymorphisms and haplotypes of eNOS in breast cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee KM, Choi JY, Lee JE, Noh DY, Ahn SH, Han W, Yoo KY, Hayes RB, Kang D (2007) Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res Treat

  2. Royo JL, Moreno-Nogueira JA, Galan JJ, Gonzalez-Martin A, Ruiz A, Gonzalez-Mancha R, Real LM (2006) Lack of Association Between NOS3 Glu298Asp and Breast Cancer Risk: a Case-ontrol Study. Breast Cancer Res Treat 100:331–333

    Article  PubMed  CAS  Google Scholar 

  3. Hefler LA, Grimm C, Lantzsch T, Lampe D, Koelbl H, Lebrecht A, Heinze G, Tempfer C, Reinthaller A, Zeillinger R (2006) Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 98:151–155

    Article  PubMed  CAS  Google Scholar 

  4. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms. Nitric Oxide 12:177–182

    Article  PubMed  CAS  Google Scholar 

  5. Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719–725

    Article  PubMed  CAS  Google Scholar 

  6. Sandrim VC, de Syllos RW, Lisboa H R, Tres GS, Tanus-Santos JE (2007) Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16:348–355

    Article  PubMed  CAS  Google Scholar 

  7. Sandrim VC, de Syllos RWC, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189:241–246

    Article  PubMed  CAS  Google Scholar 

  8. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186:428–432

    Article  PubMed  CAS  Google Scholar 

  9. Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno Jr H, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 24:2393–2397

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, PO Box 6111, 13081-970, Sao Paulo, Brazil

    Heitor Moreno Jr.

Authors
  1. Heitor Moreno Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heitor Moreno Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno , H. Genetic polymorphisms and haplotypes of eNOS in breast cancer . Breast Cancer Res Treat 109, 181–182 (2008). https://doi.org/10.1007/s10549-007-9630-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9630-8

Keywords

Search

Navigation